Non-alcoholic fatty liver disease (NAFLD), now often referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), affects about 25–32% of adults worldwide—with prevalence higher among men (30–40%) compared to women (20–30%) .
The condition progresses from simple fat accumulation to inflammatory steatohepatitis (MASH) and, eventually, to fibrosis or cirrhosis if untreated.
Fortunately, early detection means MASLD can often be effectively reversed through lifestyle changes, medical therapy, or a combination of both.
1. Eliminate Added Sugars, Especially Fructose
High intake of fructose—commonly from table sugar and high-fructose corn syrup—promotes fat buildup in the liver, triggers inflammation, and worsens insulin resistance.
Reducing or cutting out sweetened beverages, processed snacks, and sugary treats, and instead choosing whole fruits, can significantly decrease liver fat.
2. Intermittent Fasting & Caloric Timing
Limiting food intake to an 8–10 hour window (with 14–16 hours of fasting) activates autophagy, enhances insulin sensitivity, and optimizes lipid metabolism—all helping to reduce hepatic fat storage.
Though not suitable for everyone, this pattern consistently shows benefits in trials targeting metabolic syndrome and liver health.
3. Regular Physical Activity
Exercise boosts insulin sensitivity and supports liver function—even without weight loss. A 2018 meta-analysis revealed that combining aerobic exercise with resistance training lowers liver fat, improves mitochondrial function, and reduces inflammation.
Aim for at least 150 minutes of moderate-to-vigorous cardio weekly, plus two strength training sessions and 8,000–10,000 daily steps.
4. Increase Protein & Fiber Intake
Protein-rich foods (e.g., eggs, fish, legumes) help manage hunger, preventing overeating. Fiber-rich whole grains, vegetables, seeds, and fruits support gut health and slow fat absorption. Together, they contribute to reducing liver fat and improving metabolic markers.
5. Replace Refined Carbohydrates with Whole Grains & Healthy Fats
Refined carbs—white bread, pastries, chips—spike blood sugar and increase fat deposition in the liver. Swap them for brown rice, quinoa, sweet potatoes, and nutritious fats like olive oil, avocados, nuts, and seeds—ingredients featured prominently in Mediterranean-style diets’
6. Achieve Sustainable Weight Loss
Losing just 5–10% of body weight can dramatically reduce liver fat and stall disease advancement; losing 10–40% may reverse even MASH
Focus on gradual, consistent weight loss through diet and exercise for best long-term outcomes.
New & Emerging Therapies
Semaglutide (GLP‑1 Agonists)
A landmark Phase III trial involving ~800 participants with MASH found that weekly semaglutide injections (often sold under brand names such as Ozempic and Wegovy) resulted in:
Fat and inflammation reduction in ~63% of users (vs 34% placebo),
Fibrosis improved in 37% of users (vs 22% placebo),
Average weight loss of ~10.5% over 72 weeks
Side effects included mild gastrointestinal symptoms. Experts highlight their transformative potential—but note that long-term safety and sustained benefit data are still needed.
FDA-approved treatment for MASH, resmetirom (brand name Rezdiffra), is also available, though it helps only about 30–40% of patients improve.
Hormone FGF21
Animal studies using FGF21—a metabolic hormone—demonstrated reversal of liver fat buildup and fibrosis by sending signals to both the brain and liver. These results suggest FGF21-related drugs under development may act similarly to GLP‑1 therapies.
Other Experimental Treatments
Promising early-phase trials and investigational compounds include:
Aramchol, a fatty-acid bile-acid conjugate reducing liver fat in Phase IIa trials.
HU6, a prodrug targeting mitochondrial uncoupling, reduced liver fat by >30% in Phase IIa trials.
AZD2693, an antisense treatment targeting the PNPLA3 gene variant implicated in fatty liver risk.
ARO-HSD, an RNA interference therapy aimed at reducing HSD17β13 activity, part of early human trials .
While these options are still experimental, they represent hopeful additions to the future therapeutic arsenal for MASLD/MASH.
Holistic Lifestyle Strategies
Limit alcohol intake or abstain: Even moderate consumption can speed fibrosis in MASLD.
Consume moderate coffee: Coffee’s antioxidant compounds may reduce liver inflammation.
Adopt a Mediterranean dietary pattern: Rich in vegetables, whole grains, legumes, healthy fats, and lean protein—this diet reduces insulin resistance and hepatic fat’
Incorporate functional foods: Snacks like walnuts with dates, dark chocolate with nuts, berries, yogurt, and spices such as turmeric and cinnamon can further support liver health—when consumed mindfully.
Manage metabolic comorbidities: Controlling diabetes, high blood pressure, and dyslipidemia is essential to protecting liver function and reducing cardiovascular risk
Bottom Line
Early-stage fatty liver disease is largely reversible. Implementing a multifaceted approach—removing added sugars and processed carbs, engaging in regular exercise, eating more fiber and protein, fasting intermittently, and maintaining healthy body weight—can clear excess liver fat, improve liver function, and reduce metabolic risk.
Emerging therapies, particularly GLP‑1 agonists like semaglutide and investigational compounds, show promising results for those with more advanced disease. Nevertheless, long-term safety and sustained benefits are under study.
For personalized guidance, patients should consult with their healthcare provider. Combining lifestyle modification with medical treatments offers the best chance for recovery and long-term liver health.
Related topics:
